Find link

language:

Find link is a tool written by Edward Betts.

searching for Thiazolidinedione 56 found (86 total)

SLC39A11 (382 words) [view diff] exact match in snippet view article find links to article

Anand S (2010). "Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and

DUSP23 (468 words) [view diff] exact match in snippet view article find links to article

et al. (2010). "Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and

NCAPH2 (460 words) [view diff] exact match in snippet view article find links to article

et al. (2010). "Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and

Glutathione peroxidase 6 (555 words) [view diff] exact match in snippet view article find links to article

et al. (2010). "Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and

MAPK12 (938 words) [view diff] exact match in snippet view article find links to article

et al. (2010). "Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and

MAPK13 (1,013 words) [view diff] exact match in snippet view article find links to article

et al. (2010). "Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and

MASP2 (protein) (1,482 words) [view diff] exact match in snippet view article

Anand S (2010). "Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and

PDSS2 (732 words) [view diff] exact match in snippet view article find links to article

et al. (2010). "Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and

Complement component 6 (910 words) [view diff] exact match in snippet view article find links to article

et al. (2010). "Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and

Glutathione peroxidase 5 (884 words) [view diff] exact match in snippet view article find links to article

et al. (2010). "Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and

CDGSH iron sulfur domain (231 words) [view diff] exact match in snippet view article find links to article

mitochondrial protein ("mitoNEET") cross-linked specifically by a thiazolidinedione photoprobe". Am. J. Physiol. Endocrinol. Metab. 286 (2): E252–60.

CCDC57 (458 words) [view diff] exact match in snippet view article find links to article

et al. (2010). "Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and

SAA4 (517 words) [view diff] exact match in snippet view article find links to article

(October 2010). "Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and

25-Hydroxyvitamin D 1-alpha-hydroxylase (1,496 words) [view diff] exact match in snippet view article find links to article

(Oct 2010). "Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and

Thiamine transporter 1 (1,882 words) [view diff] exact match in snippet view article find links to article

(October 2010). "Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and

MAP4K3 (643 words) [view diff] exact match in snippet view article find links to article

Anand S (2010). "Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and

ZFAND5 (370 words) [view diff] exact match in snippet view article find links to article

(October 2010). "Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and

Cell growth regulator with EF-hand domain 1 (249 words) [view diff] exact match in snippet view article find links to article

Anand S (2010). "Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and

Wd repeat domain 76 (287 words) [view diff] exact match in snippet view article find links to article

(October 2010). "Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and

SDHD (2,718 words) [view diff] exact match in snippet view article find links to article

(October 2010). "Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and

STARD8 (816 words) [view diff] exact match in snippet view article find links to article

(Oct 2010). "Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and

Ring finger protein 157 (262 words) [view diff] exact match in snippet view article find links to article

(October 2010). "Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and

Glutathione peroxidase 3 (1,455 words) [view diff] exact match in snippet view article find links to article

(October 2010). "Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and

Frederick Masoudi (586 words) [view diff] exact match in snippet view article find links to article

Inzucchi SI, Havranek EP, Setaro JF, Krumholz HF. Metformin and thiazolidinedione use in Medicare patients with heart failure. JAMA 2003;290:81-85.

SPRED1 (1,498 words) [view diff] exact match in snippet view article find links to article

(October 2010). "Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and

Calreticulin (2,452 words) [view diff] exact match in snippet view article find links to article

(Oct 2010). "Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and

FRMPD4 (362 words) [view diff] exact match in snippet view article find links to article

Anand S (2010). "Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and

Glycogen branching enzyme (2,823 words) [view diff] exact match in snippet view article find links to article

(October 2010). "Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and

Pejvakin (699 words) [view diff] exact match in snippet view article find links to article

(October 2010). "Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and

FEM1A (559 words) [view diff] exact match in snippet view article find links to article

(October 2010). "Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and

Disco interacting protein 2 homolog c (553 words) [view diff] exact match in snippet view article find links to article

(October 2010). "Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and

Disco interacting protein 2 homolog c (553 words) [view diff] exact match in snippet view article find links to article

(October 2010). "Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and

CD86 (3,221 words) [view diff] exact match in snippet view article find links to article

(October 2010). "Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and

SDHB (2,957 words) [view diff] exact match in snippet view article find links to article

et al. (2010). "Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and

Ferm domain containing 4b (430 words) [view diff] exact match in snippet view article find links to article

Anand S (2010). "Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and

FADS2 (1,507 words) [view diff] exact match in snippet view article find links to article

et al. (2010). "Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and

SAMD4A (404 words) [view diff] exact match in snippet view article find links to article

(October 2010). "Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and

Branched-chain amino acid (3,420 words) [view diff] exact match in snippet view article find links to article

et al. (November 2009). "Mechanisms of human insulin resistance and thiazolidinedione-mediated insulin sensitization". Proceedings of the National Academy

ATOH8 (gene) (485 words) [view diff] exact match in snippet view article

Anand S (2010). "Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and

Mitogen-activated protein kinase kinase kinase 6 (546 words) [view diff] exact match in snippet view article find links to article

(October 2010). "Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and

AUTS2 (817 words) [view diff] exact match in snippet view article find links to article

Anand S (2010). "Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and

Haptocorrin (1,810 words) [view diff] exact match in snippet view article find links to article

(Oct 2010). "Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and

Wd repeat containing planar cell polarity effector (327 words) [view diff] exact match in snippet view article find links to article

Anand S (2010). "Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and

CAMK1G (gene) (550 words) [view diff] exact match in snippet view article

(October 2010). "Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and

OSBPL9 (895 words) [view diff] exact match in snippet view article find links to article

(Oct 2010). "Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and

Phospholipase A2 group IVD (550 words) [view diff] exact match in snippet view article find links to article

Anand S (2010). "Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and

TNIP3 (gene) (576 words) [view diff] exact match in snippet view article

(October 2010). "Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and

WNK3 (929 words) [view diff] exact match in snippet view article find links to article

et al. (2010). "Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and

Bromo adjacent homology domain containing 1 (934 words) [view diff] exact match in snippet view article find links to article

Anand S (2010). "Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and

Integrin subunit beta like 1 (481 words) [view diff] exact match in snippet view article find links to article

(October 2010). "Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and

Endothelin 2 (2,419 words) [view diff] exact match in snippet view article find links to article

(October 2010). "Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and

Heat shock protein family a (hsp70) member 12b (689 words) [view diff] exact match in snippet view article

(October 2010). "Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and

Andrej Janež (1,264 words) [view diff] exact match in snippet view article find links to article

PMID 12031980. Hevener, A. L.; Reichart, D.; Janez, A.; Olefsky, J. (2001). "Thiazolidinedione Treatment Prevents Free Fatty Acid-Induced Insulin Resistance in Male

TMEM70 (1,276 words) [view diff] exact match in snippet view article find links to article

(October 2010). "Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and

Leonid Poretsky (2,820 words) [view diff] exact match in snippet view article find links to article

D; Park, A; Patel, P; Holcomb, K; Chang, P; Poretsky, L (2005). "Thiazolidinedione action in the human ovary: direct effects on steroidogenesis and insulin-like

Biomarkers of diabetes (2,140 words) [view diff] exact match in snippet view article find links to article

agents such as metformin, glucagon/glucagonlike peptide1analogues, thiazolidinedione, sirtuin 1 activators, and lipoic acid. A study showed that when fibroblast